Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

UMN PHARMA INC.

Home Clinical Trial Sponsors and OrganizationsUMN PHARMA INC.

UMN PHARMA INC.

1-8-2, MARUNOUCHI, Chiyoda-Ku, Tokyo, Japan

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

4

50.0%

Phase 2

3

37.5%

Phase 1

1

12.5%

Trial Status Distribution

Completed

8

100.0%

Clinical Trials

Trials sponsored by this organization (8)

A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

Feb 201555 participants

Study of ASP7374, Cell-culture-derived Influenza Vaccine

Oct 2013900 participants

A Study to Evaluate Intramuscular ASP7374

Oct 201355 participants

Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine

Oct 20121,020 participants

A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers

Jul 2011180 participants

A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

May 2011165 participants

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Oct 201087 participants

Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults

Oct 200990 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations